Company intelligence / Profile preview
U-Neuron Biomedical Inc
New Taipei City/Xizhi District, New Taipei City, Taiwanemis.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
U-Neuron Biomedical is developing new drugs based on allogeneic amniotic fluid stem cells, with lead programs targeting erectile dysfunction and dry eye. The company also markets cosmetics and healthcare consumer products using deer amniotic fluid stem cell derivatives. Most sales are domestic in Taiwan. No published late-stage clinical results as of the latest available data[1][2][3].
- Therapeutic areas
- OphthalmologyMen's Health
- Modalities
- Allogeneic amniotic fluid stem cells and derivativesAutologous stem cell transplantationExosomes[1][2][3][5]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on U-Neuron Biomedical Inc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on U-Neuron Biomedical Inc.